Phase 2 Neurotrophic Keratitis Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Neurotrophic Keratitis
TearSolutions, Inc.54 enrolled3 locationsNCT07568730
Recruiting
Phase 2
A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
Neurotrophic Keratitis
Staidson (Beijing) Biopharmaceuticals Co., Ltd48 enrolled1 locationNCT06975748
Recruiting
Phase 1Phase 2
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
Neurotrophic Keratitis
Krystal Biotech, Inc.60 enrolled9 locationsNCT06999733
Recruiting
Phase 2
Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
Neurotrophic Keratitis
BRIM Biotechnology Inc.12 enrolled1 locationNCT05927428